References
- Tacke F, Schoffski P, Luedde T, Meier PN, Ganser A, Manns MP, et al. Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease. Scand J Gastroenterol 2004;39:259–66.
- Tacke F, Luedde T, Manns MP, Trautwein C. Regulation of plasma erythropoietin in chronic liver disease. World J Gastroenterol 2004;10:2922–3.
- Bruno CM, Neri S, Sciacca C, Bertino G, Di Prima P, Cilio D, et al. Plasma erythropoietin levels in anaemic and nonanaemic patients with chronic liver diseases. World J Gastroenterol 2004;10:1353–6.
- Siciliano M, Tomasello D, Milani A, Ricerca BM, Storti S, Rossi L. Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia. Hepatology 1995;22:1132–5.
- Streetz KL, Tacke F, Leifeld L, Wustefeld T, Graw A, Klein C, et al. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases. Hepatology 2003;38:218–29.